Major pharmaceutical companies are profiting immensely from the second-leading cause of death in the United States by saddling cancer patients with tens of thousands of dollars in out-of-pocket costs, often forcing them to choose between treatment and other basic necessities. But many people living with cancer in the U.S. will soon see long-overdue relief thanks to provisions of the Inflation…
This post was originally published on Latest – Truthout.